Shares of Genflow Biosciences plc (LON:GENF – Get Free Report) shot up 5% on Thursday . The company traded as high as GBX 2.10 and last traded at GBX 2.10. 989,842 shares were traded during trading, a decline of 52% from the average session volume of 2,064,951 shares. The stock had previously closed at GBX 2.
Genflow Biosciences Price Performance
The company’s 50 day moving average price is GBX 1.99 and its two-hundred day moving average price is GBX 2.06. The firm has a market cap of £11.89 million, a PE ratio of -6.33 and a beta of 2.27.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
See Also
- Five stocks we like better than Genflow Biosciences
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
- Amazon’s Zoox Push Tests Tesla’s Robotaxi Premium as Waymo Widens Its Lead
- MarketBeat Week in Review – 08/24 – 08/28
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
